# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 6f3q:A (1.45) | BS01 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
2 | 6f3q:A (1.45) | BS02 | ADE | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
3 | 6f3q:A (1.45) | BS03 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
4 | 6f3q:B (1.45) | BS01 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
5 | 6f3q:B (1.45) | BS02 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
6 | 6f3q:B (1.45) | BS03 | ADE | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
7 | 6f3q:C (1.45) | BS01 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
8 | 6f3q:C (1.45) | BS02 | ADE | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
9 | 6f3q:C (1.45) | BS03 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
10 | 6f3q:D (1.45) | BS01 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
11 | 6f3q:D (1.45) | BS02 | NAD | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 | |
12 | 6f3q:D (1.45) | BS03 | ADE | 3.13.2.1 | GO:0004013 ... | Q9I685 | 30054521 |